3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
7
Wilms Tumor
6
Rhabdoid Tumor
5
Osteosarcoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Multiple Myeloma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Lung Neoplasms
4
Central Nervous System Neoplasms
4
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Sarcoma, Ewing
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Mycosis Fungoides
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Positron-Emission Tomography
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
X-Rays
×
30 days
×
Clear all
No trials found.